Success in cancer care increasingly includes survivorship outcomes, emphasizing durable function and symptom control for patients cured and those with prolonged metastatic disease. Variable survival ...

We are curing more cancers than we used to,” Cottrill said. “Recurrent cancers are more challenging to cure than cancers that ...

Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival ...

Limited screening, lack of awareness and unequal access to healthcare continue to worsen survival rates, posing a major ...

Molecular recurrence signals preceded symptoms or imaging in all recurrences observed, indicating ctDNA may enable earlier ...

Investigators sought to determine whether complementary and alternative medicine (CAM) affects survival in female patients with breast cancer.

An open-label non–HLA-A*02 cohort showed a 0.7% annualized recurrence rate after primary immunization with GLSI-100, measured over an average 1.2 patient-years of exposure. Historical comparison to ...

Erda-iDRS delivers erdafitinib into the bladder over three months, enabling localised therapy and reducing systemic exposure.

Good news: cancer death rates in the UK have fallen to their lowest level on record. According to the latest statistics from ...

The biopsy came back positive. It’s lung cancer.” Countless people in our community hear these words no one ever expects.

A new study co-authored by University of Kentucky Markey Cancer Center researchers Jessica Burris, Ph.D., Timothy Mullett, M.D., and Graham Warren, M.D., Ph.D., shows that making smoking cessation ...

Scientists at Georgetown University's Lombardi Comprehensive Cancer Center have uncovered a new dual function for a ...